{
    "organizations": [],
    "uuid": "e65eae49a55661060d75c4abaee3f62e9868ead5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-easywell-biomedicals-us-unit-tulex/brief-easywell-biomedicals-u-s-unit-tulex-pharmaceuticals-signs-agreement-with-well-known-transnational-pharmaceutical-company-idUSL4N1QC0KP",
    "ord_in_thread": 0,
    "title": "BRIEF-Easywell Biomedicals U.S. unit Tulex Pharmaceuticals signs agreement with well-known transnational pharmaceutical company",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - Easywell Biomedicals Inc :\n* Says its U.S. unit Tulex Pharmaceuticals signs agreement with a well-known transnational pharmaceutical company on new drug development\nSource text in Chinese: goo.gl/L7xTxU\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-22T09:51:00.000+02:00",
    "crawled": "2018-02-22T17:53:39.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "easywell",
        "biomedicals",
        "inc",
        "say",
        "unit",
        "tulex",
        "pharmaceutical",
        "sign",
        "agreement",
        "transnational",
        "pharmaceutical",
        "company",
        "new",
        "drug",
        "development",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}